Meeting
2022 ASCO Annual Meeting
Treatment patterns of patients with glioblastoma multiforme in the real-world setting in a developing country.
Authors
Juan José Sánchez Hernández
Hospital de Oncologia Centro Medico Nacional Siglo XXI, Mexico City, Mexico
Juan José Sánchez Hernández , Santiago Zarroca Palacio , Raul Rogelio Trejo Rosales , Yuly Andrea Remolina Bonilla , Dulce Angelica De Jesus Hernandez , Miriam Najar , Nestor Javier Lizcano Aguilar , Marco Antonio Hernandez Castillo , Andrea Cruz , Amairany Guadalupe Vélez Martínez , Eduardo Sanchez , Karina Morales Hernández , Angel Gabriel Ignacio Irigoyen Álvarez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Primary CNS Tumors–Glioma
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 2067)
DOI
10.1200/JCO.2022.40.16_suppl.2067
Abstract #
2067
Poster Bd #
405
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio.
First Author: Paul James Mulholland
Poster
2015 ASCO Annual Meeting
Defining the cutoff value of MGMT gene promoter methylation and its predictive capacity.
First Author: Andrea Rocca
Poster
2014 ASCO Annual Meeting
Association of high volume center with survival for glioblastoma patients: Results from a prospective population-based registry (PERNO).
First Author: Alba Ariela Brandes
Poster
2013 ASCO Annual Meeting
The Stupp regimen preceded by early post-surgery temozolomide versus the Stupp regimen alone in the treatment of patients with newly diagnosed glioblastoma multiforme (GBM).
First Author: LF Zhou